|
Volumn 3, Issue 1, 2002, Pages 5-9
|
A pilot study to determine the feasibility of continuous cefazolin infusion
a a a a a c b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA LACTAM ANTIBIOTIC;
CEFAZOLIN;
ARTICLE;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
DRUG BLOOD LEVEL;
DRUG SAFETY;
DRUG TISSUE LEVEL;
HUMAN;
INTERMETHOD COMPARISON;
MAJOR CLINICAL STUDY;
PERIOPERATIVE PERIOD;
POSTOPERATIVE PERIOD;
PREOPERATIVE PERIOD;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
SIDE EFFECT;
SUBCUTANEOUS FAT;
SURGICAL INFECTION;
VENOUS BLOOD;
WOUND CLOSURE;
ANTI-BACTERIAL AGENTS;
ANTIBIOTIC PROPHYLAXIS;
CEFAZOLIN;
CORONARY ARTERY BYPASS;
DRUG ADMINISTRATION SCHEDULE;
FEASIBILITY STUDIES;
HUMANS;
INFUSIONS, INTRAVENOUS;
PILOT PROJECTS;
PROSPECTIVE STUDIES;
SUBCUTANEOUS TISSUE;
SURGICAL WOUND INFECTION;
TREATMENT OUTCOME;
|
EID: 0036236483
PISSN: 10962964
EISSN: None
Source Type: Journal
DOI: 10.1089/109629602753681104 Document Type: Article |
Times cited : (29)
|
References (13)
|